Chemomab Therapeutics Ltd... (CMMB)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
2.05
-0.03 (-1.44%)
At close: Jan 28, 2025, 3:00 PM
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY12 |
PE Ratio | -4.95 | -26.34 | -114.02 | -173.17 | -28.36 | -158.22 | -15.9 | -198.38 | -104.91 | 4.29 |
PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 7.05 | 20.11 | 23.29 | 95.07 | 51.75 | 222.66 | -256.08 | 285.13 | 366.86 | 31.55 |
P/FCF Ratio | -5.07 | -35.63 | -113.5 | -194.49 | -46.46 | -151.23 | -18.24 | -247.17 | -105.36 | n/a |
P/OCF Ratio | -5.08 | -35.75 | -115.69 | -195.9 | -46.73 | -153.49 | -18.31 | -252.2 | -106.61 | n/a |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 0.02 | 0.01 | 0.01 | 0.04 | 0.07 | n/a | n/a | n/a | n/a | n/a |
Quick Ratio | 4.32 | 6.18 | 41.58 | 9.50 | 4.42 | 4.00 | 0.59 | 2.07 | 2.32 | 1.87 |
Current Ratio | 4.32 | 6.18 | 23.66 | 9.00 | 4.42 | 3.98 | 0.59 | 2.07 | 2.32 | 1.87 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | -80.83 | -111.64 | -995.33 | -2.18K | n/a | -1.88K | n/a | -503.81 | n/a |
Return on Equity (ROE) | -1.43 | -0.76 | -0.2 | -0.55 | -1.83 | -1.41 | 16.10 | -1.44 | -3.5 | 7.35 |
Return on Assets (ROA) | -1.09 | -0.64 | -0.2 | -0.48 | -1.38 | -1.08 | -4.7 | -0.84 | -2.13 | 2.55 |
Return on Capital (ROIC) | -1.47 | -0.79 | -0.2 | -0.54 | -1.25 | -1.3 | 15.42 | -1.41 | -3.27 | 5.26 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |